• Blog
  • Intermittent Catheter Market Report

    Intermittent Catheter Market Report

    Intermittent Catheter Market Report
    Report code - SR2174 Delivery - 2 Weeks
    Intermittent Catheter Market Size, Share, Trend, Forecast, Competitive Analysis, and Growt See more...

    Market Insights

    The intermittent catheter market was estimated at US$ 1.9 billion in 2021 and is expected to grow at a CAGR of 5.01% during 2022-2028 to reach US$ ~3.40 billion in 2028.

    An intermittent catheter is a temporary medical device that is used to drain urine from the bladder. A drainage bag is included with intermittent catheters to help collect urine. These catheters are made of silicone, red rubber latex, vinyl, or polyvinyl chloride (PVC). The urine flows down the catheter tube and into the collecting bag after these catheters are put into the urethra and guided to the bladder. Furthermore, these catheters allow for self-catheterization. Catheterization skills can be taught to children between the ages of 7-8.

    An increase in the number of elderly people and an increase in urine incontinence are the two main market-driving reasons for intermittent catheters. Additionally, the implementation of favourable reimbursement guidelines for catheters is anticipated to support market expansion. The availability of alternatives to intermittent catheters and domestic price rivalry, however, restrain market expansion. On the other hand, a surge in disposable money and greater knowledge of intermittent catheters are expected to create profitable opportunities in emerging markets.

    The rise in demand for less invasive operations are what are fueling the market for intermittent catheters. Additionally, a rise in the popularity of hydrophilic intermittent catheters is anticipated to support market expansion. The availability of intermittent catheter substitutes and a lack of consumer knowledge of new intermittent catheters, however, restrain market expansion. However, improvements in catheter technology and product launches are projected to offer opportunities for the market expansion.

    A significant factor impeding the growth of the global market for urinary catheters is the rise in the frequency of urinary tract infections. For instance, the prevalence of UTI was 10% among illnesses connected with nursing homes, according to the Epidemiology & Prevention of UTI NHSN 2018 Training brief from the National Center for Emerging and Zoonotic Infectious Diseases. Additionally, the availability of disposable incontinence products such pull-on absorbent pants and adult diapers is anticipated to restrain the growth of the global urinary catheter market.

    Several investments/guidelines in the industry have been directed in recent years, which would boost the overall market. Some of them are:

    • Over the forecast period, rising urinary incontinence instances are anticipated to fuel market expansion for urinary catheters. For instance, 63 million people globally experienced urgent urine incontinence in 2018, according to the International Continence Society.
    • Additionally, a growing geriatric population is anticipated to fuel market expansion. For instance, the World Health Organization predicts that by 2050, there will be 2 billion people who are elderly.

    Segment Analysis

    Based on type, product type, application, end user, and geography, the market has been divided into segments. Coated and uncoated are the market segments for intermittent catheter that have been created based on product type. The coated intermittent catheter segment is expected to grow at the fastest rate owing to high technological advancements. Because they have a low coefficient of friction and are biocompatible & long-lasting, coated catheters decrease bacterial adherence. These coated catheters also have low coefficients of friction, are resistant to solvents, enable aqueous interactions, and prevent thrombosis.

    Based on application, the intermittent catheter market has been divided into urinary incontinence, surgery, spinal cord injury, and others. The market's largest category is anticipated to be urinary incontinence segment. According to the American Urological Association, urinary incontinence affects one-third of the population and affects women more frequently than males.

    The intermittent catheter market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2021, North America is anticipated to be the intermittent catheter market's largest region. 

    Key Players

    The following are the major players in the intermittent catheter market:

    • Adapta Medica
    • B Braun Melsungen AG
    • BD
    • Coloplast
    • ConvaTec
    • Cure Medical,
    • Hollister
    • Hunter Urology
    • Pennine Healthcare
    • Teleflex

    There is stiff competition in the intermittent catheter market. The market's leading players can concentrate on creating sophisticated urinary catheters that provide catheterization that reduces the danger of leakage and infection while preventing discomfort and resentment from urethral disorders. For example:

    • The Infyna Chic intermittent catheter was introduced to the US market in March 2021 by Hollister Incorporated, an independent, employee-owned business that creates, produces, and sells healthcare products globally. The Infyna Chic catheter joins the current US product line, which already includes the VaPro and Onli intermittent catheter brands, with the goal of helping women who use catheters maintain a high level of discretion. This gives women a variety of solutions to match their specific needs.
    • A contract for the distribution of CATHETRIX's ground-breaking FoleySafe catheter securement system in Canada, the United States, and the United Kingdom was signed in November 2019 with Pro-Lab Diagnostics, a leading global distributor of medical products. CATHETRIX is an inventive developer of urinary (Foley) smart catheter fixations. The first catheter stabiliser in the world, FoleySafe actively guards against potential injury to the bladder and urethra from unintentional urinary catheter removal. Health Canada has also granted CATHETRIX an establishment authorization for its goods. The product has previously been approved by the U.S. FDA and the EU CE Mark. Pro-Lab Diagnostics is already in the process of negotiating a number of contracts for the sale of FoleySafe. The company has its headquarters in Ontario, Canada, has operations in the US and the UK, and many international affiliates.
    • In September 2019, the Netherlands government approved the reimbursement of Bactiguard's indwelling urinary catheters (Foleys), allowing healthcare professionals in the home care market to provide patients Bactiguard's products for infection control and to enhance their quality of life.
    • In July 2019, Hollister Incorporated revealed that Vizient, Inc., the biggest member-driven organisation focused on improving the performance of the nation's healthcare system, had awarded their VaPro No Touch Intermittent Catheter with the 2019 Innovative Technology recognition. The designation was made on the advice of medical professionals who participated in a council run by members and engaged with the device at the Vizient Innovative Technology Exchange in April. The council came to the conclusion that the technology could improve clinical treatment, patient safety, healthcare worker safety, or the operational efficiency of healthcare organisations.
    • A contract for innovative technology was awarded to Poiesis Medical's Duette Dual Balloon Indwelling Urinary Catheter by Vizient, Inc., the biggest member-driven health care performance improvement firm in the nation, in March 2019. Hospital professionals in this field who sit on one of Vizient's member-led councils recommended the Duette Catheter, which served as the foundation for the contract.
    • The single-use Actreen Mini Catheter and the Actreen Mini Set were unveiled by B. Braun Medical Inc. in May 2017 at the American Urological Association (AUA) annual meeting in Boston. Women who require an intermittent catheter due to urinary retention or a voiding problem can use the tiny, lightweight Actreen Mini Catheter.
    • The US Food and Drug Administration (FDA) gave the PerfIC Cath intermittent touchless urinary catheter its seal of approval in October 2016. The catheters have an introducer tip that avoids areas with plenty of bacteria, lowering the risk of infection. They also have a hydrophilic covering for completely lubricating the catheter and facilitating simple transit into the bladder. The catheters are additionally covered in a protective sheath for disposal ease and to prevent fluid from coming in contact with the user.

    The overall competitive landscape has been affected due to these mergers and acquisitions. 

    Research Methodology

    This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

    • Market structure: Overview, industry life cycle analysis, supply chain analysis
    • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
    • Market trend and forecast analysis
    • Market segment trend and forecast
    • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
    • Attractive market segments and associated growth opportunities
    • Emerging trends
    • Strategic growth opportunities for the existing and new players
    • Key success factors

    Frequently Asked Questions (FAQs)

    The intermittent catheter market is estimated to reach at US$ ~3.40 billion in 2028.

    The intermittent catheter market is growing at a CAGR of 5.01% over the forecast period.

    The top players in the market are Adapta Medica, B Braun Melsungen AG, BD, Coloplast, ConvaTec, Cure Medical, Hollister, Hunter Urology, Pennine Healthcare, Teleflex.

    The intermittent catheter market is studied from 2016 - 2028.

    An intermittent catheter is a temporary medical device that is used to drain urine from the bladder. A drainage bag is included with intermittent catheters to help collect urine. These catheters are made of silicone, red rubber latex, vinyl, or polyvinyl chloride (PVC).

    An increase in the number of elderly people and an increase in urine incontinence are the two main market-driving reasons for intermittent catheters. Additionally, the implementation of favourable reimbursement guidelines for catheters is anticipated to support market expansion.

    In 2021, North America is anticipated to be the intermittent catheter market's largest region.